To access this element change to forms mode OFF
Grant Award View - GA202740
Neuroinflammation in schizophrenia
GA ID:
GA202740
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
23-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$2,427,015.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Neuroinflammation in schizophrenia
Purpose:
Schizophrenia is debilitating disorder in need of a cure. Inflammation along with macrophage invasion occurs in the brains of ~40-45% of the people with schizophrenia. I aim to block immune cell invasion and test if the symptoms of schizophrenia can be reversed. Through studies of the human brain, basic science studies and novel investigator initiated clinical trials, I will continue to develop strategies to dampen neuroinflammation and to prevent damaging immune cells entering the brain.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2009237
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA